Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques
Authors:
Open Access
- 1 February 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (4) , 770-778
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological ImplicationsCurrent Pharmaceutical Design, 2014
- Selegiline Reverses Aβ25–35-Induced Cognitive Deficit in Male MiceNeurochemical Research, 2013
- Dopamine Modulates Episodic Memory Persistence in Old AgeThe Journal of Neuroscience, 2012
- Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs DiseaseCNS Drugs, 2011
- Cognitive deficits and striato-frontal dopamine release in Parkinson's diseaseBrain, 2008
- Reversal of age-related deficits in object recognition memory in rats with l-deprenylExperimental Gerontology, 2005
- Dopamine and cognitive functionCurrent Opinion in Neurology, 2003
- Oxidative α-Ketoglutarate Dehydrogenase Inhibition via Subtle Elevations in Monoamine Oxidase B Levels Results in Loss of Spare Respiratory CapacityJournal of Biological Chemistry, 2003
- Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged ratsPharmacology Biochemistry and Behavior, 1991
- Cognitive effects of l-deprenyl in Alzheimer's diseasePsychopharmacology, 1987